Acalabrutinib in patients with mantle cell lymphoma subjected to allogeneic hematopoietic cell transplantation. a phase 2 study by the Polish Lymphoma Research Group (PLRG12 trial)
- DOI
- 10.1007/s00277-026-07178-8
- Published
- 2026-07-17
- Container
- Annals of Hematology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00277-026-07178-8,
title = {Acalabrutinib in patients with mantle cell lymphoma subjected to allogeneic hematopoietic cell transplantation. a phase 2 study by the Polish Lymphoma Research Group (PLRG12 trial)},
author = {Sebastian Giebel and Anna Czyż and Iwona Hus and Lidia Gil and Krzysztof Giannopoulos and Joanna Romejko-Jarosińska and Maciej Majcherek and Agnieszka Szeremet and Anna Wache and Paulina Kwaśnik and Ryszard Swoboda and Wojciech Jurczak},
year = {2026},
journal = {Annals of Hematology},
doi = {10.1007/s00277-026-07178-8},
url = {https://doi.org/10.1007/s00277-026-07178-8}
}RIS
TY - JOUR TI - Acalabrutinib in patients with mantle cell lymphoma subjected to allogeneic hematopoietic cell transplantation. a phase 2 study by the Polish Lymphoma Research Group (PLRG12 trial) AU - Sebastian Giebel AU - Anna Czyż AU - Iwona Hus AU - Lidia Gil AU - Krzysztof Giannopoulos AU - Joanna Romejko-Jarosińska AU - Maciej Majcherek AU - Agnieszka Szeremet AU - Anna Wache AU - Paulina Kwaśnik AU - Ryszard Swoboda AU - Wojciech Jurczak PY - 2026 JO - Annals of Hematology DO - 10.1007/s00277-026-07178-8 UR - https://doi.org/10.1007/s00277-026-07178-8 ER -
APA
Giebel, S., Czyż, A., Hus, I., Gil, L., Giannopoulos, K., Romejko-Jarosińska, J., Majcherek, M., Szeremet, A., Wache, A., Kwaśnik, P., Swoboda, R., & Jurczak, W. (2026). Acalabrutinib in patients with mantle cell lymphoma subjected to allogeneic hematopoietic cell transplantation. a phase 2 study by the Polish Lymphoma Research Group (PLRG12 trial). Annals of Hematology. https://doi.org/10.1007/s00277-026-07178-8
Source records
- crossref · retrieved 2026-09-27T12:22:08.536Z